[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK142544C - Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf - Google Patents

Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf

Info

Publication number
DK142544C
DK142544C DK226476A DK226476A DK142544C DK 142544 C DK142544 C DK 142544C DK 226476 A DK226476 A DK 226476A DK 226476 A DK226476 A DK 226476A DK 142544 C DK142544 C DK 142544C
Authority
DK
Denmark
Prior art keywords
imidazoline
phenylamino
propargyl
analogue
derivatives
Prior art date
Application number
DK226476A
Other languages
Danish (da)
English (en)
Other versions
DK226476A (da
DK142544B (da
Inventor
H Staehle
H Koeppe
W Kummer
K Stockhaus
W Hoefke
F J Kuhn
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK226476A publication Critical patent/DK226476A/da
Publication of DK142544B publication Critical patent/DK142544B/da
Application granted granted Critical
Publication of DK142544C publication Critical patent/DK142544C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK226476A 1975-05-24 1976-05-21 Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf DK142544C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2523103 1975-05-24
DE2523103A DE2523103C3 (de) 1975-05-24 1975-05-24 Substituierte 2-[N-Progargyl-N-(2-chlorphenyl)amino] -imidazoline-^), deren Säureadditionssalze, Verfahren zu ihrer Herstellung und deren Verwendung

Publications (3)

Publication Number Publication Date
DK226476A DK226476A (da) 1976-11-25
DK142544B DK142544B (da) 1980-11-17
DK142544C true DK142544C (da) 1981-08-17

Family

ID=5947354

Family Applications (1)

Application Number Title Priority Date Filing Date
DK226476A DK142544C (da) 1975-05-24 1976-05-21 Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf

Country Status (31)

Country Link
US (1) US4025607A (cs)
JP (1) JPS601310B2 (cs)
AT (1) AT350552B (cs)
AU (1) AU501016B2 (cs)
BE (1) BE842118A (cs)
BG (1) BG34036A3 (cs)
CA (1) CA1067905A (cs)
CH (1) CH621116A5 (cs)
CS (1) CS185596B2 (cs)
DD (1) DD126391A5 (cs)
DE (1) DE2523103C3 (cs)
DK (1) DK142544C (cs)
ES (1) ES448175A1 (cs)
FI (1) FI62070C (cs)
FR (1) FR2312243A1 (cs)
GB (1) GB1513320A (cs)
GR (1) GR60385B (cs)
HU (1) HU172452B (cs)
IE (1) IE43711B1 (cs)
IL (1) IL49629A (cs)
LU (1) LU75006A1 (cs)
MX (1) MX3636E (cs)
NL (1) NL7605539A (cs)
NO (1) NO144215C (cs)
NZ (1) NZ180913A (cs)
PL (1) PL98961B1 (cs)
PT (1) PT65121B (cs)
SE (1) SE422937B (cs)
SU (1) SU578871A3 (cs)
YU (1) YU39275B (cs)
ZA (1) ZA763046B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MTP837B (en) 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE2806811A1 (de) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine, deren saeureadditionssalze, diese enthaltene arzneimittel und verfahren zur herstellung derselben
DE2806775A1 (de) * 1978-02-17 1979-08-30 Boehringer Sohn Ingelheim Neue substituierte 2-phenylimino- imidazolidine deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE2832310A1 (de) * 1978-07-22 1980-02-07 Boehringer Sohn Ingelheim Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
US4255439A (en) * 1979-07-13 1981-03-10 Irving Cooper Means and method for aiding individuals to stop smoking
DE2947563A1 (de) * 1979-11-26 1981-06-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE2949287A1 (de) * 1979-12-07 1981-06-11 C.H. Boehringer Sohn, 6507 Ingelheim Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE3124718A1 (de) 1981-06-24 1983-01-13 Boehringer Ingelheim KG, 6507 Ingelheim Neue imidazo (1,2-a)pyramidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE3321282A1 (de) * 1983-06-13 1984-12-13 Boehringer Ingelheim KG, 6507 Ingelheim Neue 1-acetonyl-2-(phenylimino)-imidazolidine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
MW7087A1 (en) * 1986-10-03 1988-05-11 Hoffmann La Roche 1,3-disubstituted imidazolium salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759125A (fr) * 1969-11-19 1971-05-18 Boehringer Sohn Ingelheim Nouvelles n-allyl-2-arylamino-imidazolines-(2) substituees et procedes pour les fabriquer
US3850926A (en) * 1971-01-21 1974-11-26 Boehringer Sohn Ingelheim 2-(n-substituted-phenylamino)-imidazolines-(2)
AT330380B (de) * 1971-06-16 1976-06-25 Inst Elektroswarki Patona Verfahren zur herstellung mehrschichtiger metallblocke
BE787683A (fr) * 1971-08-20 1973-02-19 Boehringer Sohn Ingelheim 2-phenylimino-imidazolidines, leurs sels d'addition avec des acides et procedes pour les fabriquer

Also Published As

Publication number Publication date
HU172452B (hu) 1978-09-28
CH621116A5 (cs) 1981-01-15
ATA317276A (de) 1978-11-15
AU1417076A (en) 1977-11-24
NZ180913A (en) 1978-07-28
YU126276A (en) 1982-02-28
PT65121B (de) 1978-07-03
IE43711L (en) 1976-11-24
IL49629A0 (en) 1976-07-30
CS185596B2 (en) 1978-10-31
PL98961B1 (pl) 1978-06-30
US4025607A (en) 1977-05-24
MX3636E (es) 1981-04-13
SE7605819L (sv) 1976-11-25
PT65121A (de) 1976-06-01
NO144215B (no) 1981-04-06
ZA763046B (en) 1978-01-25
DE2523103C3 (de) 1979-11-29
DE2523103A1 (de) 1976-12-09
GB1513320A (en) 1978-06-07
NL7605539A (nl) 1976-11-26
SU578871A3 (ru) 1977-10-30
DD126391A5 (cs) 1977-07-13
SE422937B (sv) 1982-04-05
ES448175A1 (es) 1977-07-01
DK226476A (da) 1976-11-25
IE43711B1 (en) 1981-05-06
JPS601310B2 (ja) 1985-01-14
AU501016B2 (en) 1979-06-07
CA1067905A (en) 1979-12-11
LU75006A1 (cs) 1977-12-22
JPS525768A (en) 1977-01-17
FI761406A (cs) 1976-11-25
BE842118A (fr) 1976-11-22
IL49629A (en) 1979-09-30
FI62070B (fi) 1982-07-30
YU39275B (en) 1984-10-31
NO144215C (no) 1981-07-15
FR2312243A1 (fr) 1976-12-24
BG34036A3 (en) 1983-06-15
AT350552B (de) 1979-06-11
GR60385B (en) 1978-05-24
DK142544B (da) 1980-11-17
FR2312243B1 (cs) 1979-09-28
FI62070C (fi) 1982-11-10
NO761744L (cs) 1976-11-25
DE2523103B2 (de) 1979-04-12

Similar Documents

Publication Publication Date Title
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK147362C (da) Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK145119C (da) Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf
DK151331C (da) Analogifremgangsmaade til fremstilling af 5-pyridinyl-2(1h)-pyridinon-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK149594C (da) Analogifremgangsmaade til fremstilling af dipeptidderivater eller syreadditionssalte heraf
DK162714C (da) Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf
DK151009C (da) Analogifremgangsmaade til fremstilling af benzhydrylsulfinylforbindelser og fysiologisk acceptable syreadditionssalte deraf
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK150512C (da) Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK149630C (da) Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf
DK147858C (da) Analogifremgangsmaade til fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte dera
DK151017C (da) Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf
DK154950C (da) Analogifremgangsmaade til fremstilling af 1-(benzazolylalkyl)-piperidinderivater eller de farmaceutisk acceptable syreadditionssalte deraf
DK142544C (da) Analogifremgangsmaade til fremstilling af 2-(n-propargyl-n-phenylamino)-imidazolin-(2)-derivater eller fysiologisk acceptable syreadditionssalte heraf
DK144127C (da) Analogifremgangsmaade til fremstilling af lysergsyre- eller 9,10-dihydrolysergsyreamider eller syreadditionssalte deraf
DK149231C (da) Analogifremgangsmaade til fremstilling af enkephalin-analoge tetrapeptidamider eller syreadditionssalte deraf
DK159079A (da) Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
DK149841C (da) Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK146066C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf
DK165005C (da) Analogifremgangsmaade til fremstilling af 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater eller terapeutisk acceptable salte deraf
DK143278C (da) Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PBP Patent lapsed